Skip to content

Clinical trial to evaluate the efficacy of Suvarn prashan drops in reducing respiratory infections in children.

"A randomized controlled clinical trial to evaluate the efficacy of Suvarn prashan drops (herbo-mineral formulation) in reducing the respiratory infection in infants"

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/09/028159
Enrollment
60
Registered
2020-09-30
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Suvarn Prashan Avaleham: Trial drug Herbo-Mineral Formulation (Suvarn Prashan Avaleham) 2 drops early morning empty stomach daily for three months Control Intervention1: Sugar Drops: Co

Sponsors

Dr Vasishths Ayu Remedies
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Infants aged from 06 months to 09 months of either Gender. 2. Parentsâ?? willingness to let their children participate.

Exclusion criteria

Exclusion criteria: 1. Subjects suffering from major systemic illness necessitating long term treatment. 2. Co-morbidity like TB, UTI and bleeding disorders etc. 3. H/o hypersensitivity to any of the trial drug or their ingredients.

Design outcomes

Primary

MeasureTime frame
To lower down the incidence of respiratory infection in infants with the use of trial drug.Timepoint: baseline and every 15th day up to completion of trial i.e. end of 4 months

Secondary

MeasureTime frame
To promote the normal growth and development of infant with lowering the incidence of infection.Timepoint: Total trial period : 03 Months Follow-Up Period : 01 Month

Countries

India

Contacts

Public ContactDr Rakesh Kumar Nagar

National Institute of Ayurveda

drnishaojha@gmail.com9468650449

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026